iScience (Apr 2021)

A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection

  • Jane E. Sinclair,
  • Yanshan Zhu,
  • Gang Xu,
  • Wei Ma,
  • Haiyan Shi,
  • Kun-Long Ma,
  • Chun-Feng Cao,
  • Ling-Xi Kong,
  • Ke-Qiang Wan,
  • Juan Liao,
  • Hai-Qiang Wang,
  • Matt Arentz,
  • Meredith A. Redd,
  • Linda A. Gallo,
  • Kirsty R. Short

Journal volume & issue
Vol. 24, no. 4
p. 102264

Abstract

Read online

Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with multiple direct and indirect cardiovascular complications. We sought to analyze the association of host co-morbidities (chronic respiratory illnesses, cardiovascular disease [CVD], hypertension or diabetes mellitus [DM]) with the acute cardiovascular complications associated with SARS-CoV-2 infection. Individual analyses of the majority of studies found median age was higher by ~10 years in patients with cardiovascular complications. Pooled analyses showed development of SARS-CoV-2 cardiovascular complications was significantly increased in patients with chronic respiratory illness (odds ratio (OR): 1.67 [1.48, 1.88]), CVD (OR: 3.37 [2.57, 4.43]), hypertension (OR: 2.68 [2.11, 3.41]), DM (OR: 1.60 [1.31, 1.95]) and male sex (OR: 1.31 [1.21, 1.42]), findings that were mostly conserved during sub-analysis of studies stratified into global geographic regions. Age, chronic respiratory illness, CVD, hypertension, DM, and male sex may represent prognostic factors for the development of cardiovascular complications in COVID-19 disease, highlighting the need for a multidisciplinary approach to chronic disease patient management.

Keywords